The ageing entero-insular axis

Diabetologia

Volumn 41, Issue 11, 1998, Pages 1309-1313

  Ranganath, L ^a   Sedgwick, I ^b   Morgan, L ^b   Wright, J ^b   Marks, V ^b  

^a EPSOM GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Elderly; GIP; GLP 1; Glucose; Insulin; Menopause

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PEPTIDE HORMONE;

ADULT; AGED; AGING; ARTICLE; CARBOHYDRATE INTAKE; FEMALE; GLUCOSE INTOLERANCE; HORMONE RESPONSE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL;

ACETAMINOPHEN; ADULT; AGED; AGING; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLUCOSE INTOLERANCE; HUMANS; INSULIN; PEPTIDE FRAGMENTS; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 0031739724     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051070     Document Type: Article

References (29)

1. Harris MI, Hidden WC, Knowler WC (1987) Prevalance of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74 years. Diabetes 36: 523-534
2. Fitzgerald MG, Kilvert A (1985) Glucose tolerance and aging. In: Brockehurst JC (ed) Textbook of Geriatric Medicine and Gerontology. Churchill Livingstone, pp 718-719
3. Muller DC, Elahi D, Tobin JD, Andres R (1996) The effect of age on insulin resistance and secretion: a review. Semin Nephrol 16: 289-298
4. Scheen AJ, Sturis J, Polonsky KS, Van Cauter E (1996) Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging. Diabetologia 39: 564-572
5. Bourey RE, Kohrt WM, Kirwan JP, Staten MA, King DS, Holloszy JO (1993) Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontology 48:M122-M127
6. Shimizu M, Kawazu S, Tomono S et al. (1996) Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin ratio in the elderly, but not in obese, subjects without glucose intolerance. Diabetes Care 19: 8-11
7. Borg LA, Dahl N, Swenne I (1995) Age-dependent differences in insulin secretion and intracellular handling of insulin in isolated pancreatic islets of the rat. Diabetes Metabol 21: 408-414
8. Perfetti R, Rafizadeh CM, Liotta AS, Egan Jm (1995) Age-dependent reduction in insulin secretion and insulin mRNA in isolated islets from rats. Am J Physiol 269: E983-E990
9. Aizawa T, Komatsu M, Sato Yet al. (1994) Insulin secretion by the pancreatic beta cell of aged rats. Pancreas 9: 454-459
10. McIntyre N, Holdsworth CD, Turner DS (1964) New interpretation of oral glucose tolerance. Lancet II: 20-21
11. Morgan LM (1992) Insulin secretion and the entero-insular axis. In: Flatt PR (ed) Nutrient regulation of insulin secretion. The Biochemical Society, Portland Press, London, pp 1-22
12. Fehmann HC, Goke R, Goke B (1995) Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Endocr Rev 16: 390-410
13. Ranganath LR (1996) The role of glucagon-like peptide-1 and lipoprotein lipase in health and obesity. [Thesis] University of Surrey, Guildford, UK
14. Heading RC, Nimmo J, Prescott LF, Tothill P (1973) The dependence of paracetamol absorption on the rate of gastric emptyying. Br J Pharmacol 47: 415-421
15. Gainsborough N, Maskrey VL, Nelson ML et al. (1993) The association of age with gastric emptying. Age and Ageing 22: 37-40
16. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V (1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 138: 159-166
17. Morgan LM, Morris BA, Marks V (1978) Radioimmunoassay of gastric inhibitory polypeptide. Ann Clin Biochem 15: 172-177
18. Miholic J, Orskov C, Holst JJ, Kotzerke J, Meyer HJ (1991) Emptying of gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycaemia after total gastrectomy. Dig Dis Sci 36: 1361-1370
19. Miholic J, Orskov C, Holst JJ, Schaper S (1993) Postprandial GLP-1 in patients after esophageal resection, total gastrectomy and massive small-bowel resection. Digestion 54: 386-388
20. Triggs EJ, Nation RL, Long A, Ashley JJ (1975) Pharmacokinetics in the elderly. Eur J Clin Pharmacol 8: 55-62
21. Galinsky RE, Corcoran GB (1986) Influence of advanced age on the formation and elimination of acetaminophen metabolites by male rats. Pharmacology 32: 313-320
22. Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36 amide), peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214: 829-835
23. Macs M, Scharpe S, De Meester I et al. (1994) Components of biological variation in prolyl endopeptidase and dipeptidyl peptidase IV activity in plasma of healthy subjects. Clin Chem 40: 1686-1691
24. Schmidt WE, Siegel EG, Kummel H, Gallwitz B, Creutzfeldt W (1987) Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33/-39. Endocrinology 120: 835-837
25. Thorens B (1993) Recent studies on the GLP-1 receptors. Digestion 54: 341-342
26. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide-1 (GLP-1) (7-36)amide but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with type-2 diabetes mellitus. J Clin Invest 30: 301-307
27. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC (1993) The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 23: 466-473
28. O'Sullivan AJ, Ho KK (1995) A comparison of the benefits of oral and transdermal oestrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 80: 1783-1788
29. Godsland IF, Gangar K, Walton C et al. (1993) Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42: 846-853